Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

Joseph R. Berger, Diego Centonze, Giancarlo Comi, Christian Confavreux, Gary Cutter, Gavin Giovannoni, Ralf Gold, Hans Peter Hartung, Fred Lublin, Augusto Miravalle, Xavier Montalban, Paul O'Connor, Tomas Olsson, Chris H. Polman, Olaf Stuve, Jerry S. Wolinsky, Tjalf Ziemssen

Research output: Contribution to journalLetterpeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Considerations on discontinuing natalizumab for the treatment of multiple sclerosis'. Together they form a unique fingerprint.